A woman in her 50s became the first patient to receive Amchepry, Japan's conditionally approved iPS-cell therapy for Parkinson's disease, at Kyoto University Hospital. Sumitomo Pharma says she is recovering well and has returned to work.
Charité in Berlin has given Germany's first routine CRISPR-based treatment to a 19-year-old with beta-thalassemia. Four months later his hemoglobin is normal and he no longer needs transfusions.
University of Bonn researchers converted blood cells directly into neural stem cells and found their epigenetic clocks reset, so cells from an 80-year-old ended up with a molecular age below 20.
In a first-in-human trial in Murcia, Spain, 10 women with advanced osteoporosis received their own stem cells with a sugar tag that steers them to bone marrow. No serious side effects occurred and fractures fell sharply, but the study had no control group.
University at Buffalo researchers grew tiny salivary glands from human stem cells. Transplanted into mice, they survived more than 40 days and formed saliva-making cells, an early step toward treating severe dry mouth after cancer radiation.